Home » Topics » Regulatory

Regulatory
RSS

Cabergoline: new use in restless legs syndrome

Oct. 14, 1999

Panel recommends Pfizer's Zoloft for Rx of posttraumatic stress disorder

Oct. 13, 1999

PDE3 inhibitor olprinone is an effective bronchodilator in asthma patients

Oct. 13, 1999

FDA approves Prozac for treatment of geriatric depression

Oct. 12, 1999

AstraZeneca receives FDA approval of Rhinocort Aqua Nasal Spray

Oct. 7, 1999

FDA approves Pfizer's Tikosyn

Oct. 6, 1999

FDA approves new indication for Topamax

Oct. 6, 1999

ASBMR participants learn of efficacy, safety of risedronate in several large studies

Oct. 5, 1999

Yale study will evaluate memantine's ability to prevent vision loss in glaucoma patients

Oct. 4, 1999

FDA approves Evista for treatment of postmenopausal osteoporosis

Oct. 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.